ArticleThe American surgeon2022
Thromboelastography-Based Evaluation of Gender-Associated Hypercoagulability.
Article in The American surgeon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 14 citations in OpenAlex.
- Platelet Reactivity and Sex Differences: Clinical Implications for Women.Circulation research · 2026Review
- Evaluation of a Point-of-Care Viscoelastic Coagulation Monitor (VCM Vet) and Thromboelastography (TEG) in Bonobos (Pan paniscus).Journal of medical primatology · 2026Article
- Plasma Constituents Promote Endothelial Thromboinflammatory Dysfunction After Hemorrhagic Shock.Shock (Augusta, Ga.) · 2026Article
- An assessment of green plasma: The in vitro hemostatic superiority of a currently discarded blood product.Transfusion · 2026Article
- Liquid Trisilanol i-Octyl POSS Achieves Rapid Hemostasis and Pneumostasis in Experimental Lung Injury.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025Article
- Comparison of Different Sampling Methods on Viscoelastic Test Results Using a Point-of-Care Coagulation Monitor in Healthy Dogs.Veterinary clinical pathology · 2025Article
- Pre-operative reference ranges for ROTEMAnaesthesia · 2025Observational
- Trends in pulmonary embolism mortality in cancer patients in the United States from 1999-2022- A CDC Wonder database study.Respiratory research · 2025Article
- Prothrombotic Biomarkers Are Not Altered by Wood Smoke: A Pilot Controlled Exposure Study.FASEB bioAdvances · 2025Article
- Thromboelastography Use: Sex, a Possible Predictor of Thrombosis in Peripheral Artery Disease.The Journal of surgical research · 2025Article
- Arterial Junctional Hemostasis without Compression: Evaluation of Visco-liquid Hemostats in Male SwineBiomaterials and biosystems · 2025Article
- Impact of BMI and PRP Platelet and Red Blood Cell Content on the Coagulation Kinetics of Ortho-R/PRP Mixtures.Polymers · 2025Article
- The impact of sex on platelet responses to aspirin in patients with peripheral artery disease.American journal of hematology · 2024Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundAge, race, and gender differences in coagulation status of healthy volunteers have been reported in previous case series; however, rigorous multivariate analysis adjusting for these factors is lacking. We aimed to investigate the effects of age, race, and gender on baseline coagulation status in healthy volunteers.
methodsThirty healthy volunteer controls with no history of bleeding or thrombotic events and no previous anticoagulant or antiplatelet use were recruited. Citrated and heparinized blood samples were drawn, and kaolin and platelet-mapping thromboelastography (TEG) assays performed.
resultsThirty participants had a mean age of 37, mean body mass index of 29 kg/m DISCUSSION: Women at baseline have relatively hypercoagulable fibrin deposition kinetics, platelet contributions to clot formation, and overall clot strength compared to men, even when adjusted for age and race. Additional research is needed to specifically detail the key patient-level factors, clinical implications, and opportunities for tailored therapy related to gender-associated hypercoagulability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.